Summary
CareDx, Inc. (CareDx) is a molecular diagnostics company that discovers, develops, and commercializes clinically differentiated and non-invasive tests to monitor immune status in transplant recipients. It focuses on developing diagnostic surveillance solutions for autoimmune disease and potentially improve long-term patient outcomes. The company commercializes AlloMap molecular expression testing, which aids clinicians in identifying heart transplant recipients with stable graft function. CareDx applies genomics and bioinformatics technology to develop molecular diagnostic assays based on gene expression patterns in blood cells that provide clinically useful information. It partners and collaborates with pharmaceutical and biotech companies, medical centers, and academic institutions in developing biological markers. CareDx is headquartered in Brisbane, California, the US.
CareDx, Inc. (CDNA) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
CareDx, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
CareDx, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
CareDx, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
CareDx, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 9
CareDx, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
CareDx, Inc., Medical Equipment, Deal Details 11
Venture Financing 11
XDx Secures US$2.2 Million In Venture Financing 11
XDx Secures US$6.04 Million In Financing Round 12
Partnerships 13
Diaxonhit Enters Into Licensing And Distribution Agreement With XDx For AlloMap Molecular Expression Testing 13
CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 15
CareDx Enters into Co-Development Agreement with Horizon Discovery 16
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 17
CareDx Terminates Co-Development Agreement with LabCorp 18
Equity Offering 19
CareDx Prices IPO for USD40 Million 19
CareDx, Inc. - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Strategy And Business Planning 24
Nov 02, 2015: CareDx Completes Expansion of CLIA Laboratory With Next-Generation Sequencing Platform Capability 24
Financial Announcements 25
Mar 24, 2016: CareDx Reports Fourth Quarter and Full Year 2015 Financial Results 25
Nov 11, 2015: CareDx Reports Third Quarter 2015 Financial Results 26
Aug 10, 2015: CareDx Reports Second Quarter 2015 Financial Results 27
May 12, 2015: CareDx Reports First Quarter 2015 Financial Results 28
Mar 17, 2015: CareDx Reports Fourth Quarter and Full Year 2014 Financial Results 29
Corporate Communications 31
Mar 29, 2016: CareDx Announces New Chief Commercial Officer Todd Whitson 31
Mar 24, 2016: CareDx Announces CFO Transition 32
Mar 03, 2015: CareDx Appoints William A. Hagstrom to Its Board of Directors 33
Jan 05, 2015: CareDx Appoints John J. Sninsky, Ph.D. as Chief Scientific Officer 34
Product News 35
Mar 08, 2016: CareDx Receives Positive Coverage Decision for AlloMap From TRICARE Covering Over 9 Million Lives of U.S. Military Members and Their Families 35
Jan 12, 2016: CareDx and Diaxonhit Announce Completion of Technology Transfer of AlloMap Test in Europe 36
Nov 17, 2015: CMS Revises Its Pricing Determination for AlloMap 37
Nov 09, 2015: CareDx Presents Donor-Derived Cell-Free DNA Data at the Association for Molecular Pathology and American Society of Nephrology Annual Meetings 38
Oct 18, 2015: CareDx CEO to Present at CMS Panel Meeting on Monday, October 19 at 8:45am ET 39
May 04, 2015: CareDx Announces First Patients Enrolled in Largest-Ever Multicenter Kidney Transplant Study Using Cell-Free DNA Technology 40
Apr 16, 2015: CareDx Cell-Free DNA (cfDNA) Biomarker in Combination With AlloMap(R) Increases Accuracy of Identification of Rejection in Heart Transplant Recipients 41
Apr 08, 2015: CareDx to Present New Data on AlloMap(R) and Cell-Free DNA Biomarker in Heart Transplant Recipients at ISHLT 2015 42
Jan 12, 2015: DIAXONHIT announces that Strasbourg University Hospital will become its European Central Laboratory for processing the CareDx AlloMap heart transplant tests 44
Clinical Trials 45
May 04, 2015: CareDx Announces First Patients Enrolled in Largest-Ever Multicenter Kidney Transplant Study Using Cell-Free DNA Technology 45
Other Significant Developments 46
Aug 06, 2015: CareDx and DNAnexus Collaborate on Cloud-Based Genomics Platform for Cell-Free DNA 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
List of Tables
CareDx, Inc., Medical Equipment, Key Facts, 2014 1
CareDx, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
CareDx, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
CareDx, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
CareDx, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
CareDx, Inc., Deals By Market, 2010 to YTD 2016 9
CareDx, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
XDx Secures US$2.2 Million In Venture Financing 11
XDx Secures US$6.04 Million In Financing Round 12
Diaxonhit Enters Into Licensing And Distribution Agreement With XDx For AlloMap Molecular Expression Testing 13
CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 15
CareDx Enters into Co-Development Agreement with Horizon Discovery 16
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 17
CareDx Terminates Co-Development Agreement with LabCorp 18
CareDx Prices IPO for USD40 Million 19
CareDx, Inc., Key Competitors 21
CareDx, Inc., Key Employees 22
List of Figures
CareDx, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
CareDx, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
CareDx, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
CareDx, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
CareDx, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
CareDx, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 7
CareDx, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
CareDx, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 9
